MDT

87.72

+0.7%↑

116.95

+1.62%↑

VEEV

157.12

+3.74%↑

HQY

79.57

+1.86%↑

TLRY

6.74

+2.43%↑

MDT

87.72

+0.7%↑

116.95

+1.62%↑

VEEV

157.12

+3.74%↑

HQY

79.57

+1.86%↑

TLRY

6.74

+2.43%↑

MDT

87.72

+0.7%↑

116.95

+1.62%↑

VEEV

157.12

+3.74%↑

HQY

79.57

+1.86%↑

TLRY

6.74

+2.43%↑

MDT

87.72

+0.7%↑

116.95

+1.62%↑

VEEV

157.12

+3.74%↑

HQY

79.57

+1.86%↑

TLRY

6.74

+2.43%↑

MDT

87.72

+0.7%↑

116.95

+1.62%↑

VEEV

157.12

+3.74%↑

HQY

79.57

+1.86%↑

TLRY

6.74

+2.43%↑

Home・Aktien・Lisata Therapeutics

L
Lisata Therapeutics

Open

4.99 -0.2

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

4.98

Max

5.01

Schlüsselkennzahlen
By Trading Economics
Einkommen	1.3M -3M
Verkäufe	100K 100K
Gewinnspanne	-2,954
Angestellte	21

Dividenden
By Dow Jones
Nächstes Ergebnis	7. Mai 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-208K 39M
Vorheriger Eröffnungskurs	5.19
Vorheriger Schlusskurs	4.99

Lisata Therapeutics Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

12. Apr. 2026, 23:44 UTC

Market Talk

Wichtige Nachrichtenereignisse

Nikkei Likely to Fall After U.S.-Iran Peace Talks Break Down -- Market Talk

12. Apr. 2026, 23:38 UTC

Market Talk

Wichtige Nachrichtenereignisse

Oil Climbs as U.S.-Iran Peace Talks Fail, U.S. Navy Starts Blockade of Strait of Hormuz -- Market Talk

12. Apr. 2026, 23:38 UTC

Market Talk

Australia's Upstream Energy Companies Poised for Consensus Earnings Upgrades -- Market Talk

12. Apr. 2026, 23:36 UTC

Market Talk

Wichtige Nachrichtenereignisse

Gold Falls as Dollar Strengthens After U.S.-Iran Peace Talks Collapse -- Market Talk

12. Apr. 2026, 23:31 UTC

Market Talk

A2 Milk's Supply Issues Likely Temporary -- Market Talk

12. Apr. 2026, 23:09 UTC

Market Talk

Wichtige Nachrichtenereignisse

Australian Dollar Hammered by Blockade of Iran Ports -- Market Talk

12. Apr. 2026, 23:06 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12. Apr. 2026, 23:06 UTC

Market Talk

Australian Dollar Ripe for a Downward Correction -- Market Talk

12. Apr. 2026, 22:56 UTC

Wichtige Nachrichtenereignisse

Spot Gold Falls 1.9% to $4,658.65 per Ounce

12. Apr. 2026, 22:54 UTC

Wichtige Nachrichtenereignisse

Front-Month Brent Crude Oil Futures Rise 7.6% to $102.42 per Barrel

12. Apr. 2026, 22:53 UTC

Wichtige Nachrichtenereignisse

Front-Month WTI Crude Oil Futures Rise 8.3% to $104.56 per Barrel, ICE Data Show

12. Apr. 2026, 22:51 UTC

Wichtige Nachrichtenereignisse

Front-Month Crude Oil Futures Climb After U.S.-Iran Peace Talks Break Down

12. Apr. 2026, 22:50 UTC

Market Talk

Wichtige Nachrichtenereignisse

US Dollar Climbs Amid Broad Risk Off Mood In FX Market -- Market Talk

12. Apr. 2026, 22:37 UTC

Market Talk

Wichtige Nachrichtenereignisse

Australian Dollar Under Fire as Middle East Tensions Ratchet Up Again -- Market Talk

11. Apr. 2026, 08:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

11. Apr. 2026, 08:20 UTC

Market Talk

Health Care Roundup: Market Talk

11. Apr. 2026, 08:20 UTC

Market Talk

Wichtige Nachrichtenereignisse

Basic Materials Roundup: Market Talk

11. Apr. 2026, 00:00 UTC

Ergebnisse

Akquisitionen, Fusionen, Übernahmen

Big Yachts, Big Bucks -- Barrons.com

10. Apr. 2026, 21:55 UTC

Akquisitionen, Fusionen, Übernahmen

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10. Apr. 2026, 21:01 UTC

Ergebnisse

Cango Inc.: Files Annual Report on Form 20-F With SEC

10. Apr. 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

10. Apr. 2026, 20:50 UTC

Market Talk

Wichtige Nachrichtenereignisse

Basic Materials Roundup: Market Talk

10. Apr. 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10. Apr. 2026, 20:31 UTC

Market Talk

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10. Apr. 2026, 20:10 UTC

Akquisitionen, Fusionen, Übernahmen

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10. Apr. 2026, 19:15 UTC

Market Talk

Global Energy Roundup: Market Talk

10. Apr. 2026, 19:15 UTC

Market Talk

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10. Apr. 2026, 19:08 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10. Apr. 2026, 19:08 UTC

Market Talk

U.S. Natural Gas Futures End Week Lower -- Market Talk

10. Apr. 2026, 18:38 UTC

Market Talk

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

Peer-Vergleich

Kursveränderung

Lisata Therapeutics Prognose

Rating-Konsens

By TipRanks

Neutral

1 ratings

Buy

Halten

Sell

Basierend auf 1 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Lisata Therapeutics – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Gewinn vor Steuern

Verkäufe

Betriebsergebnis

Über Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.